TP53 and hepatocellular carcinoma: Jiang et al. studied the effects of hyperoside on the apoptosis of human hepatoma HepG2 cells via the P53/caspase pathway, and found that this compound significantly increases (p < 0.05) the expression levels of P53, caspase-9 and caspase-3 proteins in HepG2 cells [23].